The global Azithromycin market volume was roughly 61 thousand tonnes in 2023 and is anticipated to grow at a CAGR of 3.5% during the forecast period until 2034.
Azithromycin, a member of the macrolide antibiotics subclass, is derived from erythromycin and exhibits both bactericidal and bacteriostatic properties. Its mechanism of action involves inhibiting the translocation step in protein synthesis by binding to the ribosomal subunit in microorganisms, thereby impeding cell growth and ultimately leading to cell death. Due to its broad-spectrum activity and high tissue penetration, Azithromycin is extensively used in clinical practice. It is predominantly prescribed for the treatment of various infections, including respiratory tract infections such as pneumonia, bronchitis, and sinusitis, as well as genitourinary tract infections like urethritis and cervicitis. Additionally, Azithromycin is indicated for treating pharyngitis, skin structure infections, and enteric infections caused by susceptible organisms. Furthermore, Azithromycin plays a crucial role in the management of sexually transmitted diseases (STDs). It is an essential component of treatment regimens for conditions such as pelvic inflammatory disease (PID) and Neisseria gonorrhea infections, providing effective therapy against these pathogens. Antibiotics like Azithromycin are ineffective against colds, flu, or other viral infections. Their unnecessary usage raises the likelihood of developing antibiotic-resistant infections in the future.
Azithromycin stands out as a highly potent antibiotic, renowned for its exceptional tissue accumulation and prolonged retention compared to alternative antibiotics. Beyond its antimicrobial properties, Azithromycin demonstrates notable immunomodulatory effects, particularly in chronic inflammatory conditions. This capability to modulate host responses has rendered Azithromycin invaluable in managing severe ailments such as cystic fibrosis, Chronic Obstructive Pulmonary Disease (COPD), and asthma, facilitating its prolonged therapeutic benefits in these challenging conditions. Consequently, there has been a surge in the utilization and demand for Azithromycin, fuelled by its multifaceted pharmacological profile. Moreover, the well-established safety and efficacy of Azithromycin serve as significant drivers for its continued growth. The escalating adoption of Azithromycin has notably revolutionized the management of specific community-acquired infections, leading to enhanced treatment outcomes. Its distinctive pharmacokinetic properties and minimal adverse-effect profile have played a pivotal role in bolstering patient adherence and compliance over the years. Recognizing the increasing significance of Azithromycin as a prophylactic agent, major pharmaceutical companies are channelling substantial investments into broadening the scope of disease indications for Azithromycin. This strategic focus on expanding the therapeutic applications of Azithromycin underscores its evolving role as a versatile and indispensable tool in combating a diverse array of infectious and inflammatory conditions. The global Azithromycin market is likely to reach approximately 90 thousand tonnes in 2034.
Geographically, North America is the largest consumer of Azithromycin and is likely to maintain its position in the upcoming years as well. Firstly, the region witnesses a notable surge in the incidence of bacterial infections, driving the demand for effective antibiotics like Azithromycin. Additionally, the robust regulatory framework and streamlined approval processes in North America facilitate the rapid introduction of new pharmaceutical products, including Azithromycin variants, further bolstering market growth. Moreover, the region's thriving pharmaceutical and biotechnology sectors play a pivotal role in driving innovation and advancing drug research and development efforts. The substantial investments by key industry players in North America to accelerate R&D activities contribute significantly to the expansion of the Azithromycin market. Furthermore, the presence of leading pharmaceutical companies and research institutions fosters collaboration and knowledge exchange, propelling the development of novel Azithromycin formulations and treatment approaches. Additionally, the region's strong healthcare infrastructure and high healthcare expenditure support the widespread adoption of advanced antibiotics like Azithromycin. Overall, these factors collectively underscore North America's position as a frontrunner in the Azithromycin market, highlighting its dominance in terms of revenue generation and its pivotal role in driving global market trends and developments.
Based on end-use applications, the global Azithromycin market is divided into Respiratory Tract Infections, Skin and Soft Tissue Infections, Sexually Transmitted Diseases, and Others. Among these industries, Respiratory Tract Infections is the major segment. Azithromycin is prescribed for infections caused by susceptible organisms, encompassing a range of conditions such as lower respiratory tract infections like bronchitis and pneumonia, skin and soft tissue infections, otitis media, and upper respiratory tract infections including sinusitis and pharyngitis/tonsillitis.
Major players in the Global Azithromycin market are Pfizer Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Zydus Cadila, Akorn, Incorporated, Sandoz International GmbH, PLIVA, Lupin, Gland Pharma Limited, WOCKHARDT, Aurobindo Pharma, CSPC Pharmaceutical Group Limited, Alembic Pharmaceuticals Limited, Betterway Pharmaceutical Group Ltd., AnkeBio Co., Ltd., and Others.
Years considered for this report:
Historical Period: 2015- 2022
Base Year: 2023
Estimated Year: 2024
Forecast Period: 2025-2034
This report will be delivered on an online digital platform with one-year subscription and quarterly update.
Objective of the Study:
• To assess the demand-supply scenario of Azithromycin which covers production, demand and supply of Azithromycin market in the globe.
• To analyse and forecast the market size of Azithromycin
• To classify and forecast Global Azithromycin market based on end-use and regional distribution.
• To examine competitive developments such as expansions, mergers & acquisitions, etc., of Azithromycin market in the globe.
To extract data for Global Azithromycin market, primary research surveys were conducted with Azithromycin manufacturers, suppliers, distributors, wholesalers and Traders. While interviewing, the respondents were also inquired about their competitors. Through this technique, ChemAnalyst was able to include manufacturers that could not be identified due to the limitations of secondary research. Moreover, ChemAnalyst analyzed various segments and projected a positive outlook for Global Azithromycin market over the coming years.
ChemAnalyst calculated Azithromycin demand across the globe by analyzing the volume of Azithromycin consumed by the End-Use Applications and the forecast is calculated based on the growth rate of end-use industries. ChemAnalyst sourced these values from industry experts and company representatives and externally validated them by analyzing the historical sales data of respective manufacturers to determine the overall market size. Various secondary sources such as company websites, association reports, annual reports, etc., were also studied by ChemAnalyst.
Key Target Audience:
• Azithromycin manufacturers and other stakeholders
• Organizations, forums and alliances related to Azithromycin distribution
• Government bodies such as regulating authorities and policy makers
• Market research organizations and consulting companies
The study is useful in providing answers to several critical questions that are important for industry stakeholders such as Azithromycin manufacturers, customers and policy makers. The study would also help them to target the growing segments over the coming years (next two to five years), thereby aiding the stakeholders in taking investment decisions and facilitating their expansion.
Report Scope:
In this report, Global Azithromycin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Attribute
Details
Market size Volume in 2023
61 thousand tonnes
Market size Volume in 2034
90 thousand tonnes
Growth Rate
CAGR of 3.5% from 2024 to 2034
Base year
2023
Estimated year
2024
Historical Data
2015 – 2022
Forecast period
2025 – 2034
Quantitative units
Demand in thousand tonnes and CAGR from 2024 to 2034
Report coverage
Industry Market Size, Capacity by Company, Capacity by Location, Operating Efficiency, Production by Company, Demand by Type, Demand by End-Use Application, Demand by Region, 9. Demand by Distribution Channel, Demand-Supply Gap, Company Share, Manufacturing Process.
Segments covered
By End-Use Application: (Respiratory Tract Infections, Skin and Soft Tissue Infections, Sexually Transmitted Diseases, and Others)
By Sales Channel: (Direct Sale and Indirect Sale)
Regional scope
North America, Europe, Asia Pacific, Middle East and Africa, and South America.
I am satisfied with overall performance of ChemAnalyst. Weekly updates before the final report were especially helpful and reassuring. Additional requests on the interim and/or final reports were handled in a swift and professional manner
Mr.Shin Dosho
Member - Board of Directors
Osaka Gas Co. Ltd
Disruption Tracker
Disruption Tracker reflect the major shutdown on monthly basis which will help you in
tracking the inventory management and smooth functioning of business. Unforeseen shutdowns and disruptions
resulting in a loss of production capacity to impact the bottom line. The capacity tracker provides industries
with a global view of production and consumption capacity loss that reflects the corresponding conversion factors.
It also highlights the immediate impact on supply due to planned and unplanned outages as well as upcoming start-up
of new capacities. Additionally, it emphasizes how each shutdown—whether due to a maintenance turnaround or a case
of force majeure, affects the plant's operating rate for the given duration. Disruption tracker gives a clear insight
into the worldwide outages affecting the commodity of interest. With every shutdown, it also reflects the impact on
supply of the product in the market at a Global level.
What was the net market size of Azithromycin in terms of volume in 2023?
Ans:
The global market size of Azithromycin has reached approximately 61 thousand tonnes in 2023.
Q2.
Which region is the leading consumer of Azithromycin?
Ans:
North America is the leading consumer of Azithromycin globally.
Q3.
Do you offer single or multiuser license?
Ans:
Online Access 12 Months – Single User License (Up to 3 users can access the database) Online Access 12 Months – Enterprise License (Up to 10 Users can access the database)
Q4.
Will I get access to the analyst who authored this report?
Ans:
You will have 24/7 access to the analyst during the subscription period.
Our Solutions
Custom Research
We at ChemAnalyst provide tailor-made solutions to our clients based on their requirements which help them in building and expanding their business by developing customized strategy such as sales strategy, GTM Strategy, product portfolio and new product development. Our dedicated team helps clients in getting the best solution for their requirements. We at ChemAnalyst look forward to serving our clients for long term association.
Techno Economic Feasibility Report (TEFR)
ChemAnalyst provide TEFR reports which include market sizing, plant cost (ISBL and OSBL units), financial modelling, covering all the major financial calculations and ratios including production cost, IRR, major technology, licensing fee (if required), and others fixed and variable costs. TEFR reports will help the client to build greenfield project as well as brownfield expansion for a specific geography. Our Team of experts have delivered multiple TEFR reports which help clients in moving ahead of their business competition by grabbing the opportunity and expanding their business portfolio.
Price Benchmarking
Pricing benchmark report provides real-time data perpetuating current market scenarios, in a world that is changing at a rapid pace, having real-time prices is an imperative to make impactful insights and thereby informed decisions. The Price Benchmarking report provides pricing data for an individual market, or group of markets, which can be converted into localized insights and comparable listings. Benchmarking Reports help clients to make informed decisions by construing the data on several filters: region, country, category, grade and subsequently increasing their brand presence. Clients majorly require pricing benchmarks when they opt for a competitive pricing strategy.